ArticleInternational journal of cancer2025

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Caroline E Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.